Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX)

CUSIP: 03168L105

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 7 signals
Share change
-1,078,221
Put/Call ratio
25%
SEC-reported price per share
$6.06
Number of holders
173
Value change
-$6,545,489
Number of buys
96
Open additional details 1 more signal available
Number of sells
52
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
348,532,261

Security key

03168L105

Report period

Q1 2024

Institutions

173

Top holders

10

Ownership snapshot

Top reported holders of AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
TPG GP A, LLC
Disclosed value leader
Fosun International Ltd
Comparable rows
0/15
Latest evidence
31 Dec 2023
13F 3/4/5 Highest disclosed value: $130,634,297 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Fosun International Ltd has the largest disclosed position value at $130.63M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Fosun International Ltd's linked filing trail.
Disclosed position value Top 5
TPG GP A, LLC $74.84M
Fosun International Ltd $130.63M
Dipan Patel $111.03M
VANGUARD GROUP INC $82.81M
BlackRock Finance, Inc. $53.7M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
TPG GP A, LLC
13F 3/4/5
Company · Former 10% Owner
—
denominator unverified
$74,835,616
12,328,767 shares
— 31 Dec 2023
Fosun International Ltd
13F
Company
13F
—
denominator unverified
$130,634,297
21,521,301 shares
— 31 Dec 2023
Dipan Patel
3/4/5
Member of 13D Group
—
denominator unverified
$111,029,165
26,905,073 shares
— 07 Nov 2023
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$82,809,287
13,642,387 shares
— 31 Dec 2023
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$53,697,775
8,846,421 shares
— 31 Dec 2023
Rubric Capital Management LP
13F
Company
13F
—
denominator unverified
$48,560,000
8,000,000 shares
— 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
173
Shares
108,100,411
Rows available
173
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders
173
Q1 2024 holders
173
Holder diff
0
Investor Q1 2024 Shares Q1 2024 Shares Share Diff Share Chg % Q1 2024 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .